Abstract
Bone loss is a known complication of severe burn injury. It is, in part, due to increased endogenous glucocorticoids that contribute to the reduction in bone formation and osteoblast differentiation, hypercalciuria secondary to hypoparathyroidism, and vitamin D deficiency. In this study we attempted to prevent post-burn bone loss by acute intravenous administration of the bisphosphonate pamidronate. We enrolled 43 children, with burns of >40% total body surface area, in a randomized, double-blind, placebo-controlled study, administering the study drug within 10 days of burn injury and again 1 week later. Dual energy X-ray absorptiometry was performed prior to drug therapy, at hospital discharge and at 6 months post-burn. Urine specimens were obtained at baseline and discharge for determination of calcium and free deoxypyridinoline. Blood was obtained along with the urine specimens for measurement of intact parathyroid hormone (iPTH) and ionized calcium (Ca) levels. Following doxycycline labeling, intra-operative iliac crest bone biopsies were obtained, and bone histomorphometry was determined. At time of discharge there were no differences in total body bone mineral content (BMC), but lumbar spine BMC was significantly higher in the pamidronate group (P<0.005). By 6 months post-burn the differences in lumbar spine BMC persisted, but, now, total body BMC was significantly higher in the pamidronate group (P<0.05). Bone histomorphometry and levels of urine Ca and free deoxypyridinoline failed to show significant increases in bone formation or decreases in bone resorption. Pamidronate did not exacerbate the hypocalcemia in burn patients. In summary, acute intravenous pamidronate administration following burns may help to preserve bone mass, perhaps by inhibiting the glucocorticoid-induced apoptosis of osteoblasts and osteocytes.
Similar content being viewed by others
References
Klein GL, Herndon DN, Langman CB et al (1995) Long-term reduction in bone mass following severe burn injury in children. J Pediatr 126:252–256
Klein GL, Herndon DN, Rutan TC, et al (1993) Bone disease in burn patients. J Bone Miner Res 8:337–345
Klein GL, Herndon DN, Goodman WG, et al (1995) Histomorphometric and biochemical characterization of bone following acute severe burns in children Bone 17:455–460
Klein GL, Bi LX, Sherrard DJ, Beavan SR, Ireland D, Compston JE, Williams WG, Herndon DN (2004) Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 15:468–474
Wimalawansa SM, Wimalawansa SJ (1999) Simulated weightlessness attenuates testosterone production resulting in bone loss. Endocrine 10:253–260
Klein GL, Nicolai M, Langman CB, Cuneo BF, Sailer DE, Herndon DN (1997) Dysregulation of calcium homeostasis following severe burn injury in children: possible role of magnesium depletion. J Pediatr 131:246–251
Murphey ED, Chattopadhyay N, Bai M, et al (2000) Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to post-burn hypocalcemia. Crit Care Med 28:3885–3890
Hart DW, Herndon DN, Klein G, et al (2001) Attenuation of post-traumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 233:827–834
Murphy KD, Thomas S, Mlcak RP, Chinkes DL, Klein GL, Herndon DN (2004) Effects of long-term oxandrolone administration in severely burned children. Surgery 136:219–224
Hart DW, Wolf SE, Mlcak RP, et al (2000) Persistence of muscle catabolism after severe burn. Surgery 128:312–319
Klein GL, Langman CB, Herndon DN (2002) Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia. J Trauma 52:346–350
Klein GL, Chen TC, Holick MF, et al (2004) Synthesis of vitamin D in skin after burns. Lancet 363:291–292
Rauch F, Plotkin H, Zeitlin L, Glorieux FH (2003) Bone mass, size, and density in children and adolescence with osteogenesis imperfecta: effect of intravenous pamidronate therapy. J Bone Miner Res 18:610–614
Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363–1374
Klein GL, Langman CB, Herndon DN (2000) Persistent hypoparathyroidism following magnesium repletion in burn-injured children Pediatr Nephrol 14:301–304
Whyte MP, Winkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349:457–463
Acknowledgments
This study was supported in part by grant 8640, Shriners Hospitals for Children, Tampa, Florida, and NIH grant 1 P50 GM 60338. The authors would like to thank Mary Kelly and Jose Martinez, Shriners Burns Hospital, Galveston, for their valuable technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klein, G.L., Wimalawansa, S.J., Kulkarni, G. et al. The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos Int 16, 631–635 (2005). https://doi.org/10.1007/s00198-004-1731-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-004-1731-1